Sensex Edges Higher, Nifty Holds 8,250; SBI, Infosys Lead Gains
12:10 p.m.: The Sensex continued to hold on to the gains while Nifty traded above 8,250 with some buying seen in IT stocks. The broader markets outperformed with BSE smallcap index up around 0.80 per cent. Infosys, SBI, Tech Mahindra and Bank of Baroda were among the top Nifty50 gainers.Â
10.10 a.m.: Bharti Infratel was the top loser in Nifty, down 2 per cent followed by BPCL and Coal India, which were down over 1.5 per cent each. Meanwhile, Hindalco was the top gainer in the Nifty, up 1.65 per cent. Tech Mahindra, Infosys, Zee and ITC were among the other top five gainer in Nifty, rising between 1.1 to 1.3 per cent.Â
10.05 a.m.:Â Sensex shed most of its early gains after pharma and banking shares witnessed selling pressure. The pharma sub-index of NSE traded 0.46 per cent lower while Nifty Bank was down 0.25 per cent.Â
9:21 a.m.: Indian markets opened higher on Friday with Sensex rising over 100 points and Nifty above 8250, tracking mostly higher global markets. Â However, markets could not sustain higher levels and pares the early gains amid some selling pressure in banking stocks.Â
9:15 a.m.: Vijay Chopra, MD & CEO of Enoch Ventures, said that Nifty is likely to face pressure at 8,300 levels.Mr Chopra said that it is too early to say that the foreign institutional investors have resumed buying in Indian markets. FIIs were big sellers in November.Â
9:14 a.m.:Â Asian stocks were mostly higher with Japan's Nikkei rising to its highest level in a year, supported by Wall Street gains and solid buying of exporters on the back of a weaker yen.
9:10 a.m.:Â Â Foreign institutional investors bought shares worth Rs 700 crore yesterday.Â
Â
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.